News Releases and Media Advisories

KDADS Awarded Strategic Prevention Framework for Prescription Drugs Grant from SAMHSA

For Immediate Release

September 15, 2021

For more information, contact:
Cara Sloan-Ramos

TOPEKA, Kan. – Kansas Department for Aging and Disability Services (KDADS) Secretary Laura Howard announced today the agency has received a five-year grant totaling $1,920,000. The grant funding is part of the federal Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention’s (CSAP), Strategic Prevention Framework for Prescription Drugs (SPX-Rx) program.

“KDADS’s ongoing work within the Strategic Prevention Framework Partnership for Success grant program made us eligible to apply for and receive these additional grant dollars,” KDADS Secretary Howard said. “We’ve already begun much of the important work necessary to strengthen prevention strategies and slow the progression of substance abuse at the community level in Kansas and these funds will enable us to build on that.”

KDADS’s Behavioral Health Services Commission received the SPX-Rx for the purpose of raising awareness about the dangers of sharing medication; to work with pharmaceutical and medical communities on the risks of overprescribing to young adults; to raise community awareness; and to increase prescription drug abuse education to schools, communities, parents, prescribers and patients. The goals of the KDADS project include:  

  • Targeting the priority issue of prescription drug misuse through state-level strategic planning processes around prescription drug misuse prevention.
  • Track reductions in opioid overdoses and incorporate K-TRACS data into needs assessments and strategic plans. (K-TRACS is the prescription drug monitoring program for the state of Kansas. It is used by prescribers and pharmacists as a clinical decision-making tool to promote patient safety and healthy communities through prevention of prescription drug misuse, abuse and diversion.)
  • In collaboration with the Kansas Board of Pharmacy and DCCCA, build upon the expertise and established SPF-based prevention infrastructures to address one of the nation’s top substance abuse prevention priorities, prescription drug misuse among youth ages 12-17 years and adults ages 18 years and older.
  • Utilize statewide and local epidemiological and K-TRACS data to identify areas where prescription drug misuse is most prevalent and identify areas where there are gaps in K-TRACS data and implement programs as appropriate.

“We are pleased to be able to partner with KDADS to continue the work of the Kansas prescription drug monitoring program to help prevent prescription drug misuse, abuse and diversion across the state,” said Alexandra Blasi, Executive Secretary of the Kansas Board of Pharmacy.

“DCCCA has had a specialty in opioid prevention and education efforts since 2015,” said Lori Alvarado, Chief Executive Officer of DCCCA. “We are pleased to partner with KDADS to further combat the overdose epidemic and guide state planning and implementation to save lives. This new funding will support the development of the new five-year state plan to address the opioid epidemic and support the expanded focus on stimulants which continue to plague our state.”

About the Substance Abuse and Mental Health Services Administration (SAMHSA)

The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services (HHS) that leads public health efforts to advance the behavioral health of the nation and to improve the lives of individuals living with mental and substance use disorders, and their families.